Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Caribou Biosciences (CRBU) Receivables - Other (2020 - 2025)

Caribou Biosciences (CRBU) has disclosed Receivables - Other for 6 consecutive years, with $1.8 million as the latest value for Q3 2025.

  • On a quarterly basis, Receivables - Other changed N/A to $1.8 million in Q3 2025 year-over-year; TTM through Sep 2025 was $1.8 million, a N/A change, with the full-year FY2024 number at $1.8 million, down 20.03% from a year prior.
  • Receivables - Other was $1.8 million for Q3 2025 at Caribou Biosciences, down from $2.0 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $7.6 million in Q2 2021 to a low of $555000.0 in Q4 2021.
  • A 5-year average of $2.3 million and a median of $1.8 million in 2024 define the central range for Receivables - Other.
  • Peak YoY movement for Receivables - Other: soared 5450.0% in 2021, then plummeted 72.37% in 2022.
  • Caribou Biosciences' Receivables - Other stood at $555000.0 in 2021, then skyrocketed by 299.1% to $2.2 million in 2022, then rose by 3.21% to $2.3 million in 2023, then decreased by 20.03% to $1.8 million in 2024, then changed by 0.0% to $1.8 million in 2025.
  • Per Business Quant, the three most recent readings for CRBU's Receivables - Other are $1.8 million (Q3 2025), $2.0 million (Q2 2025), and $1.8 million (Q1 2025).